AAD 2026Abstract 77199
Real-world effectiveness of 12 months tralokinumab treatment in patients with skin of color and moderate-to-severe atopic dermatitis
Final data from the prospective, non-interventional, international, TRACE study
Armstrong AW, Rubin C, Jarell A, Ngyuen TQ, Festini T, Vinther F, Vittrup I, Pink AE
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Atopic dermatitis & eczemaSkin of color
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1486 · Not in PubMed: details from Crossref